Zymeworks (ZYME) Stock Statistics & Valuation Metrics

Zymeworks has a market cap or net worth of $1.82B. The enterprise value is -$21.00B.

Zymeworks has 73,749,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Zymeworks’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -2.45%.

The current PE Ratio of Zymeworks is ―. Zymeworks’s PEG ratio is 0.73.

In the last 12 months, Zymeworks had revenue of 105.97M and earned -81.13M in profits. Earnings per share was -1.08.

In the last 12 months, operating cash flow was -18.94B and capital expenditures -2.87M, giving a free cash flow of -18.94B billion.

Zymeworks pays an annual dividend of ―, resulting in a dividend yield of ―

Zymeworks upcoming earnings date is May 6, 2026, Before Open (Confirmed).

Zymeworks as a current ratio of 5.52, with Debt / Equity ratio of 6803.33%

In the past 12 months, Zymeworks has paid 1.38M in taxes.

Zymeworks EV to EBITDA ratio is -2.73, with an EV/FCF ratio of 0.63.

Zymeworks has $228.80M in cash and marketable securities with $18.27B in debt, giving a net cash position of -$18.04B billion.

Gross margin is 98.40%, with operating margin of -87.34%, and net profit margin of -76.56%.

The average price target for Zymeworks is $36.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy